Imaging procedures being delayed due to global contrast dye shortage

The FDA announced a global shortage of contrast materials that it blamed on COVID-19 shutdowns in Shanghai, China, a major exporter of the medial dye. Hospitals are now being forced to make tough decisions to stretch their dwindling supplies.

Top Videos